Faulty HIV test kits: Motsoaledi blames junior officials

2012-07-16 16:21

Health Minister Aaron Motsoaledi has blamed junior officials for awarding an HIV testing kit tender to a company that was found to have provided faulty HIV rapid tests.

“Junior officials took the decision on their own without consulting the seniors,” he said.

As a result, “the company that had been found to supply defective HIV testing kits was awarded the tender”.

“If the junior officials had asked my advice before awarding the tender I would have known what to do,” Motsoaledi said.

The R22-million tender at the centre of the controversy involves SD Bioline HIV rapid tests kits. It was awarded to Durban-based company Pantech in March this year.

The kits, which are manufactured in Korea, were found to be faulty by the World Health Organisation (WHO) in November last year. This led to the product being delisted from the WHO’s approved list of HIV diagnostic products.

In February this year, the WHO issued an alert recalling more of these test kits and suggested that affected countries should stop buying or using SD Bioline kits until further test are done.

However, the following month, Treasury awarded the tender to a company that supplies the “delisted” test kits.

The provinces that received these kits are Western Cape, Northern Cape, Eastern Cape and KwaZulu-Natal.

However, early this year Motsoaledi’s spokesperson, Fidel Hadebe said: “Only the Western Cape had received the batch of SD Bioline rapid test kits that were found to be faulty.”

Even then Hadebe said: “The province had used the kits without any challenges.”

Motsoaledi expressed the same sentiments today.

He said: “No person’s life was put at risk.”

The faulty test kits were showing too much red in the test window where the results were supposed to be read.

This meant that accurate results could not be read and the affected person would have to be retested.

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24


6 myths about male cancer

It is important to be aware of the most prevalent cancer diseases amongst men in our country.


You won't want to miss...

Who are the highest paid models of 2017?
10 gorgeous plus-sized models who aren't Ashley Graham
5 top leg exercises for men
10 best dressed men of 2017
Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.